LIEBEL-FLARSHEIM COMPANY LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Phase 3
Completed
Conditions
Cerebral Arterial Diseases
Interventions
Drug: Dotarem
Other: TOF MRA
First Posted Date
2009-11-13
Last Posted Date
2016-06-16
Lead Sponsor
Guerbet
Target Recruit Count
211
Registration Number
NCT01012674
Locations
🇺🇸

Guerbet LLC, Bloomington, Indiana, United States

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Phase 3
Completed
Conditions
Cerebral Arterial Diseases
Interventions
Drug: Dotarem
Other: TOF MRA
First Posted Date
2009-11-10
Last Posted Date
2016-06-16
Lead Sponsor
Guerbet
Target Recruit Count
222
Registration Number
NCT01010932
Locations
🇺🇸

Guerbet LLC, Bloomington, Indiana, United States

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Phase 3
Terminated
Conditions
Renal Disease
Interventions
Other: Time of Flight
Drug: Dotarem
First Posted Date
2009-09-21
Last Posted Date
2016-05-26
Lead Sponsor
Guerbet
Target Recruit Count
13
Registration Number
NCT00980681
Locations
🇺🇸

Guerbet LLC, Bloomington, Indiana, United States

DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

First Posted Date
2009-08-10
Last Posted Date
2012-11-02
Lead Sponsor
Guerbet
Target Recruit Count
20
Registration Number
NCT00955617
Locations
🇫🇷

Guerbet, Roissy CDG Cedex, France

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

First Posted Date
2009-02-18
Last Posted Date
2016-05-20
Lead Sponsor
Guerbet
Target Recruit Count
33
Registration Number
NCT00845702
Locations
🇺🇸

Guerbet LLC, Bloomington, Indiana, United States

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

First Posted Date
2008-12-19
Last Posted Date
2017-08-02
Lead Sponsor
Guerbet
Registration Number
NCT00811863
Locations
🇺🇸

Radiology Consultants, Inc., Youngstown, Ohio, United States

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

First Posted Date
2008-11-19
Last Posted Date
2019-03-06
Lead Sponsor
Guerbet
Target Recruit Count
6
Registration Number
NCT00793182
Locations
🇺🇸

Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States

🇺🇸

UAB Hospital, Birmingham, Alabama, United States

🇺🇸

Providence Hospital, Washington, District of Columbia, United States

and more 10 locations

Renal Safety Evaluation After Dotarem®-Enhanced MRI

First Posted Date
2008-04-02
Last Posted Date
2015-06-09
Lead Sponsor
Guerbet
Target Recruit Count
135
Registration Number
NCT00650845
Locations
🇪🇸

Hospital San Carlos, Madrid, Spain

🇧🇪

Alg. Inwendige Ziekten -Nierziekten, Roeselare, Belgium

🇫🇷

Hôpital A. Calmette, Lille, France

and more 12 locations

A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography

Phase 4
Completed
Conditions
Arterial Occlusive Disease
First Posted Date
2007-03-15
Last Posted Date
2008-11-26
Lead Sponsor
Guerbet
Registration Number
NCT00447889
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography

Phase 4
Completed
Conditions
Diagnostic Imaging
First Posted Date
2006-09-29
Last Posted Date
2008-11-26
Lead Sponsor
Guerbet
Registration Number
NCT00382317
Locations
🇦🇹

AKH, Vienna, Austria

🇫🇷

CHU Charles Nicolle, Rouen, France

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy